VANGUARD GROUP INC - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 17 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$391,314
-25.9%
439,481
-0.2%
0.00%
Q2 2023$528,304
-26.2%
440,253
-1.0%
0.00%
Q1 2023$716,226
+565.6%
444,861
+396.1%
0.00%
Q4 2022$107,598
-23.7%
89,665
+8.1%
0.00%
Q3 2022$141,000
-28.4%
82,918
-65.4%
0.00%
Q2 2022$197,000
-25.4%
239,3910.0%0.00%
Q1 2022$264,000
-37.3%
239,391
+10.2%
0.00%
Q4 2021$421,000217,2320.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q4 2021
NameSharesValueWeighting ↓
Mayo Clinic 181,754$161,8340.31%
PERKINS CAPITAL MANAGEMENT INC 150,000$1340.13%
Nantahala Capital Management 1,250,000$1,113,0000.10%
Princeton Global Asset Management LLC 16,833$14,9880.00%
MAI Capital Management 50,000$44,5200.00%
SG Americas Securities, LLC 50,453$450.00%
Walleye Capital LLC 225,956$201,1910.00%
UBS Group AG 108$960.00%
NewEdge Advisors, LLC 2,380$2,1190.00%
OSAIC HOLDINGS, INC. 700$6230.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders